title: Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment.
authors.forename: Vincent
authors.initials: V
authors.lastname: Cogliano
authors.forename: Yann
authors.initials: Y
authors.lastname: Grosse
authors.forename: Robert
authors.initials: R
authors.lastname: Baan
authors.forename: Kurt
authors.initials: K
authors.lastname: Straif
authors.forename: Béatrice
authors.initials: B
authors.lastname: Secretan
authors.forename: Fatiha
authors.initials: F
authors.lastname: El Ghissassi
mesh_terms: D000818:Animals; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D004967:Estrogens / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D008593:Menopause; D009369:Neoplasms / Q000139:chemically induced* / Q000517:prevention & control; D011372:Progestins / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors
chemical_list: D003278:Contraceptives, Oral, Hormonal; D004967:Estrogens; D011372:Progestins